Andrew C. Jackson

Officer, Eiger BioPharmaceuticals, Inc.

Companies

Calidi Biotherapeutics, Inc.Chief financial officer Nov 2, 2023 to now¹
Ernexa Therapeutics Inc.Chief financial officer Jun 1, 2022 to Jun 6, 2022²
Flyte Aviation, Inc.Chief financial officer Sep 26, 2018 to May 24, 2022³
Flyte Aviation, Inc.Chief executive officer Dec 5, 2019 to Dec 26, 2019⁴
Eiger BioPharmaceuticals, Inc.Officer Mar 17, 2015 to Mar 17, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Flyte Aviation, Inc. VJET21,680 shares⁶$17.7K at $0.82May 20, 2022
Calidi Biotherapeutics, Inc. CLDI2,500 shares⁷$1.9K at $0.77Aug 21, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 21, 2025Bought 2,500 shares at $2.00 of Calidi Biotherapeutics, Inc.⁷
May 20, 2022Shares withheld for tax 1,361 shares at $0.30 of Flyte Aviation, Inc.⁶
Nov 22, 2021Sold 2,684 shares at $2.62 of Flyte Aviation, Inc.⁸
Nov 20, 2021Returned to company 11,759 shares of Flyte Aviation, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCalidi Biotherapeutics, Inc., Chief financial officer
2
SEC EDGARErnexa Therapeutics Inc., Chief financial officer
3
SEC EDGARFlyte Aviation, Inc., Chief financial officer
4
SEC EDGARFlyte Aviation, Inc., Chief executive officer
5
SEC EDGAREiger BioPharmaceuticals, Inc., Officer
6
SEC EDGARFlyte Aviation, Inc. shares after the filing of May 20, 2022
7
SEC EDGARCalidi Biotherapeutics, Inc. shares after the filing of Aug 21, 2025
8
SEC EDGARForm 4 filed Nov 24, 2021